Get started
Author

Ada Antypiuk

Observed name: A. Antypiuk
Observed institution: New York Blood Center
ORCID: 0009-0008-5498-3440
Observed ORCID: 0009-0008-5498-3440
OpenAlex ID: A5002577611
Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages
2022 · Edwin Patino, Divya Bhatia, et al. · JCI Insight · 56
PDF
Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease
2023 · Richa Sharma, Ada Antypiuk, et al. · Blood · 42
PDF
Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical study
2024 · Ada Antypiuk, S. Zebulon Vance, et al. · Blood · 8
Myelodysplastic Syndromes Benefit from Iron-Restricted Bone Marrow Transplant in Preclinical Mouse Model
2023 · Ada Antypiuk, Alberto Martinez, et al. · Blood · 1
PDF
Combination Therapy with Luspatercept and the Ferroportin Inhibitor Vamifeport Is Superior to Either Drug Alone in Improving Anemia and Reducing Myeloid Skewing in MDS
2023 · Ada Antypiuk, Steven Vance, et al. · Blood · 1
PDF
S288: Differential Recovery of Macrophage Iron Deficiency by Oral Iron Formulations Determines Cell Inflammatory Activation in Anemic Conditions
2023 · Ada Antypiuk, Richa Sharma, et al. · HemaSphere · 1
S275: Alteration of Iron Homeostasis Through Genetic and Pharmacologic Modulation of Ferroportin Modifies Mds Pathophysiology in a Preclinical Mouse Model
2022 · S. Z. Vance, A. Antypiuk, et al. · HemaSphere · 1
Differential recovery of macrophage iron deficiency by oral iron formulations determines inflammation and autocrine hepcidin production in iron‐deficiency anemia
2026 · Ada Antypiuk, Michela Asperti, et al. · HemaSphere
PDF
S286: Targeting Conditioning-elicited Non-transferrin-bound Iron by Tmprss6 Silencing Improves Bone Marrow Transplant Outcome
2023 · Ada Antypiuk, Alberto Martinez, et al. · HemaSphere
3207 – Genetic Iron Overload Exacerbates and Pharmacological Iron Restriction Improves Mds Pathophysiology in Preclinical Studies
2023 · Francesca Vinchi, Ada Antypiuk, et al. · Experimental Hematology
PDF
Heme and Iron Aggravate Tissue Damage in Sickle Cell Disease By Driving Macrophage Functional Reprogramming through the Coordinated Suppression of Efferocytosis and Mitochondrial Metabolism
2022 · Richa Sharma, S. Zebulon Vance, et al. · Blood
Genetic Iron Overload Aggravates and Pharmacological Iron Restriction Improves MDS Pathophysiology in a Preclinical Mouse Model
2022 · S. Zebulon Vance, Ada Antypiuk, et al. · Blood
Differential Recovery of Macrophage Iron Deficiency By Oral Iron Formulations Determines Cell Inflammatory Response in Conditions of Iron Deficiency Anemia
2022 · Ada Antypiuk, Richa Sharma, et al. · Blood
S269: Macrophage Functional and Metabolic Rewiring Through Ppar/pgc1 Modulation Improves Heme/iron-driven Defective Efferocytosis and Promotes Tissue Damage Resolution in Sickle Cell Disease
2022 · R. Sharma, S. Z. Vance, et al. · HemaSphere
Role of environmental oxygen in regulating the proteome and fatty acid composition of human embryonic stem cells
2020 · Ada Antypiuk · ePrints Soton (University of Southampton)
PDF
Works count: 15
Citation count: 110
H-index: 3
I10-index: 2
Year
Topic
Type